NP Medical News about Aged Hypertension

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Use of Antiemetic Agents in Acute Gastroenteritis

3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

5. Rapid correction of low vitamin D status in nursing home residents

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Management of hypertension in the elderly patient
Clinical Interventions in Aging, 10/01/09

Stokes GS – The prime objective of this therapy is to prevent stroke. The findings of controlled trials show that there should be no cut–off age for treatment. A holistic program for controlling cardiovascular risks should be fully discussed with the patient, including evaluation to exclude underlying causes of secondary hypertension, and implementation of lifestyle measures. The choice of antihypertensive drug therapy is influenced by concomitant disease and previous medication history, but will typically include a thiazide diuretic as the first–line agent; to this will be added an angiotensin inhibitor and/or a calcium channel blocker. Beta blockers are not generally recommended, in part because they do not combat the effects of increased arterial stiffness. The hypertension–hypotension syndrome requires case–specific management. Drug–resistant hypertension is important to differentiate from faulty compliance with medication. Patients resistant to third–line drug therapy may benefit from treatment with extended–release isosorbide mononitrate. A trial of spironolactone may also be worthwhile.

<< Previous
Pharmacogenomics: Personalizing Drug Therapy

Next >>
Physician support for diabetes patients and clinical outcomes